Evidence map›Paper›PMID 29315417›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2018

Interactive or static reports to guide clinical interpretation of cancer genomics.

Stacy W Gray, Jeffrey Gagan, Ethan Cerami, Angel M Cronin, Hajime Uno, Nelly Oliver, Carol Lowenstein, Ruth Lederman, Anna Revette, Aaron Suarez and 4 more

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Stacy W GrayCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Jeffrey GaganDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Ethan CeramiDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Angel M CroninDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Hajime UnoHarvard Medical School, Boston, MA, USA.
Nelly OliverDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Carol LowensteinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ruth LedermanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Anna RevetteDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Aaron SuarezThe Broad Institute, Cambridge, MA, USA.
Charlotte LeeHarvard Medical School, Boston, MA, USA.
Jordan BryanThe Broad Institute, Cambridge, MA, USA.
Lynette ShollDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Eliezer M Van AllenHarvard Medical School, Boston, MA, USA.

Funding

The Use of Whole-Exome Sequencing to Guide the Care of Cancer PatientsU01HG006492 · NHGRI · DANA-FARBER CANCER INST · PI JANNE, PASI A, VAN ALLEN, ELIEZER M · 2012 to 2016
$7.3M
Resistance to Emerging Androgen Deprivation Therapies in Prostate CancerK08CA188615 · NCI · DANA-FARBER CANCER INST · PI VAN ALLEN, ELIEZER M · 2014 to 2017
$708k
Empowering Cancer Patients Through Innovations in Information Technology-Based Reporting of Precision MedicineR21HS024984 · AHRQ · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI GRAY, STACY W. · 2016 to 2017
$300k
AHRQ HHS R21 HS024984NCI NIH HHS K08 CA188615NHGRI NIH HHS U01 HG006492
6 · The paper itself

Abstract

Objective: Misinterpretation of complex genomic data presents a major challenge in the implementation of precision oncology. We sought to determine whether interactive genomic reports with embedded clinician education and optimized data visualization improved genomic data interpretation. Materials and Methods: We conducted a randomized, vignette-based survey study to determine whether exposure to interactive reports for a somatic gene panel, as compared to static reports, improves physicians' genomic comprehension and report-related satisfaction (overall scores calculated across 3 vignettes, range 0-18 and 1-4, respectively, higher score corresponding with improved endpoints). Results: One hundred and five physicians at a tertiary cancer center participated (29% participation rate): 67% medical, 20% pediatric, 7% radiation, and 7% surgical oncology; 37% female. Prior to viewing the case-based vignettes, 34% of the physicians reported difficulty making treatment recommendations based on the standard static report. After vignette/report exposure, physicians' overall comprehension scores did not differ by report type (mean score: interactive 11.6 vs static 10.5, difference = 1.1, 95% CI, -0.3, 2.5, P = .13). However, physicians exposed to the interactive report were more likely to correctly assess sequencing quality (P < .001) and understand when reports needed to be interpreted with caution (eg, low tumor purity; P = .02). Overall satisfaction scores were higher in the interactive group (mean score 2.5 vs 2.1, difference = 0.4, 95% CI, 0.2-0.7, P = .001). Discussion and Conclusion: Interactive genomic reports may improve physicians' ability to accurately assess genomic data and increase report-related satisfaction. Additional research in users' genomic needs and efforts to integrate interactive reports into electronic health records may facilitate the implementation of precision oncology.

Indexed as

Data DisplayGenomicsMedical OncologyPrecision MedicineClinical CompetenceComprehensionFemaleHumansMaleNeoplasmsSequence Analysis, DNA

Identifiers

PMID29315417
PMCPMC6018970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.